CareMetx

What CareMetx does

CareMetx is a privately held specialty hub services and patient access technology company headquartered in Bethesda, Maryland, founded in 2011 by Bob Dresing and Mark Hansan. The company provides end-to-end patient access solutions for pharmaceutical and biotechnology manufacturers, including benefit verification, prior authorization support, patient enrollment into manufacturer programs, affordability services, and adherence programs, all bundled under the SignalTx solution family. CareMetx serves as an intermediary that connects patients, healthcare providers, payers, and manufacturer brand teams across the specialty therapy lifecycle, with documented scale of 80–155+ supported brands and 1.5 million+ forms processed through its provider network.

The company's technology platform centers on a digital hub with proprietary components including PX Connect (provider-facing enrollment and prior authorization workflows integrated into practice management and EHR systems), Intellicore IQ (intelligence layer that converts real-time signals into next-best-action guidance), Resilix (patient adherence and treatment experience platform acquired with Human Care Systems), and a newly launched next-generation CRM built on P3 Technology infrastructure. CareMetx holds US Patent No. 12,100,510 covering automated manufacturer program enrollment and has at least six additional pending patent applications. The platform also benefits from integrations with Veradigm (Allscripts) EHR, the Syneos Health Kinetic platform, United Rheumatology's 660+ rheumatologist network, and the PX Technology provider network of 1,300+ healthcare providers. AI is applied operationally for tasks such as the 450,000+ annual reverifications and next-best-action recommendations rather than as the foundational product layer.

The business model combines professional services fees for hub operations with subscription/recurring licensing of the technology platform, delivered through enterprise field sales targeting pharma manufacturer brand teams on multi-year contracts. CareMetx is majority owned by General Atlantic with The Vistria Group maintaining a significant stake, and is led by CEO Jim Rowe (since June 2022) with co-founder Mark Hansan serving as Executive Chairman. The company operates exclusively in the United States and has executed a sustained acquisition strategy spanning VirMedica (2018), BioSolutia (2018), Phyz Healthcare Solutions (2021), Human Care Systems (2022), PX Technology (2024), and most recently Cencora's Lash Group and TheraCom operations (April 2026), which materially expanded both brand count and operational scope.

Name

CareMetx

Legal name

CareMetx, LLC

Website

https://caremetx.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

501–1,000 employees

Short description

CareMetx is a privately held specialty hub services and patient access technology company that connects pharmaceutical manufacturers, providers, payers, and patients through its digital hub platform, supporting 155+ brands with enrollment, benefits verification, prior authorization, affordability, and adherence solutions.

Ownership category

akta.pro rank

Product category

Specialty Pharmaceutical Hub Services

NAICS

Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)

SIC

Services-Health Services (8000)

akta.pro primary industry

Pharmacy/Medication Management & Virtual MTM (Payer-Sponsored) (HLALACAK)

akta.pro secondary industries

Medication Pricing, Copay Assistance & Patient Financial Support Tools (HLACAKAN), Care Navigation, Second Opinion & Expert Medical Review (Payer-Sponsored) (HLALACAH)

Keywords

• Patient access services
• Specialty hub services
• Pharma patient support
• Benefit verification solutions
• Patient adherence technology

Headquarters

HQ city

Bethesda

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

1. Hub Services and Patient Support: CareMetx provides hub services and patient support solutions to pharmaceutical and biotechnology manufacturers, charging fees for services that include benefit verification, prior authorization support, patient enrollment, affordability services, and adherence programs. The company serves as an intermediary between manufacturers, providers, payers, and patients.
2. Technology Platform Licensing: CareMetx generates revenue through licensing its technology platform and proprietary tools (PX Connect, Intellicore IQ) to pharmaceutical manufacturer clients as part of integrated patient access solutions.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

CareMetx provides patient access solutions, patient support, and pharmacy services that connect pharmaceutical manufacturers, healthcare providers, payers, and patients. Its offerings span benefit verification, prior authorization, patient enrollment, affordability/co-pay support, adherence programs, and provider-facing workflow tools, all delivered through an integrated digital hub platform.

Differentiator

Problem solved

Functional benefit

Brands

• PX Connect: Provider-facing platform for patient enrollment, consent, and prior authorizations; streamlines administrative workflows for healthcare providers
• Resilix
• SignalTx
• Intellicore IQ

Products and services

• PX Connect Provider-facing digital platform that streamlines patient enrollment, consent collection, and prior authorization workflows within existing practice management systems, including pre-populated forms, real-time benefit verification, and digital consent capabilities. Used by healthcare providers participating in specialty therapy programs.
• Provider Hub Services

Quantifiable outcome

• Reduced patient enrollment from 7 manual steps to 2-3 digital steps
• +3 more outcomes

Named customers2 records

Segments1 record

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

Five partnerships are on record, tiered core.

• P3 TechnologycoreTechnology or Integration · 31 March 2026Technology partnership for CareMetx's next-generation CRM platform. P3 Technology provides the modern patient services platform foundation that CareMetx enhances with proprietary data models, integrations, and intelligence capabilities including custom data models optimized for specialty therapy workflows and next-best-action guidance.
• Syneos HealthcoreStrategic or Co-development Partner · 22 October 2025Strategic partnership announced via MedPath to deliver a next-generation access model for specialty medications, combining CareMetx's proprietary technology with Syneos Health's patient access and support solutions to accelerate therapy initiation and improve experiences for patients and providers.
• Syneos HealthcoreStrategic or Co-development Partner · 21 October 2025Strategic partnership to deliver a next-generation access model for specialty medications, combining CareMetx's proprietary technology with Syneos Health's patient access and support solutions. The collaboration equips Syneos Health's Field Reimbursement Management and Patient Engagement teams with CareMetx's data, insights, and Access Partner Network to proactively address access challenges, streamline activation processes, and reduce integration burden for biopharma manufacturers.
• United RheumatologycoreStrategic or Co-development Partner · 24 January 2022Partnership to better support patients with chronic inflammatory diseases including Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Lupus, and Osteoporosis. CareMetx activates intelligent prescription management solutions within United Rheumatology's network of 660+ community-based rheumatologists across 39 states.
• VeradigmcoreTechnology or Integration · 5 October 2021Integration partnership making Veradigm's AccelRx automated solutions for specialty medication enrollment available directly to CareMetx clients. Empowering Veradigm and Allscripts EHR users to access CareMetx specialty medication patient access hub services via the AccelRx platform.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Eversana: Eversana is a large commercial services provider to the life sciences industry, offering patient services, hub solutions, and specialty distribution. It competes directly with CareMetx in patient access and hub services for specialty pharma manufacturers.
• TrialCard (ZS Associates): TrialCard (now part of ZS Associates) provides patient access, affordability, and adherence services to pharma manufacturers. It is a direct peer in hub services, with strong overlap in copay assistance, patient enrollment, and adherence programs.
• Lash Group (Cencora): Lash Group is Cencora's (formerly AmerisourceBergen) hub consulting services business, providing patient access and reimbursement services to specialty pharma manufacturers. It was acquired by CareMetx in April 2026, making it the closest historical direct peer now folded into the company.
• PharmaCord: PharmaCord is an independent patient services and hub provider serving specialty pharmaceutical manufacturers. It is a direct peer in benefit verification, prior authorization, copay assistance, and adherence programs.
• CoverMyMeds (McKesson): CoverMyMeds is McKesson's electronic prior authorization and patient access platform. It competes directly with CareMetx's PX Connect and eBV solutions and represents the leading in-house alternative at a major PBM-distributor.
• Innomar Strategies (Cencora): Innomar Strategies is Cencora's Canadian specialty pharmacy and patient services business. It is a direct peer in specialty patient support services, with the U.S. Lash Group operations now under CareMetx following the 2026 acquisition.

Others

• Veradigm (Allscripts): Veradigm is the EHR and healthcare technology business that integrates with CareMetx via AccelRx for specialty medication enrollment. It is an ecosystem partner (2021 integration agreement) rather than a direct competitor, enabling CareMetx access to Allscripts EHR users.

Emerging players

• Syneos Health: Syneos Health is a CRO with growing patient access and reimbursement services. It is a strategic partner of CareMetx (2025) and an emerging player in the technology-enabled hub services space, with potential to compete more directly as its offering scales.

Broad incumbents

• IQVIA: IQVIA is a global life sciences services and technology leader offering patient support, real-world evidence, and commercialization services. It is a broad incumbent competing with CareMetx in technology-enabled patient access and specialty pharma commercialization.
• McKesson RelayHealth: RelayHealth is McKesson's healthcare connectivity and patient access business, providing benefit verification, prior authorization, and clinical messaging services. It is a broad incumbent with overlapping capabilities to CareMetx's hub services and technology stack.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/caremetx

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A5 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CareMetx